Replies to Post #1140 onEnanta Pharmaceuticals Inc (ENTA)

Replies to post #1140 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1140 on Enanta Pharmaceuticals Inc (ENTA)

10/23/15 1:48 AM

#1141 RE: DewDiligence #1140

Darn it .... I was traveling and missed the negative EV. I hope it sticks around.

10/23/15 12:31 PM

#1142 RE: DewDiligence #1140

Do you think ENTA should buy shares with Japanese milestone? How much do they need for P1 trials?

10/25/15 7:23 PM

#1153 RE: DewDiligence #1140

More musings on V-Pak (and what ESRX will do):

#msg-117976477
#msg-117976876

11/13/15 1:33 PM

#1191 RE: DewDiligence #1140

First phase-3 trial of ABT-493/ABT-530 now listed: #msg-118483600.

11/18/15 6:10 PM

#1203 RE: DewDiligence #1140

IMS forecasts $45-55B worldwide HCV-drug sales in 2020: #msg-118601117.

11/20/15 9:35 AM

#1206 RE: DewDiligence #1140

ENTA receives $30M milestone from ABBV for HCV launch in Japan:

http://www.sec.gov/Archives/edgar/data/1177648/000119312515382975/d214977d8k.htm

11/23/15 6:04 PM

#1214 RE: DewDiligence #1140

FY4Q15 CC notes: #msg-118709130.